Baolingbao Biology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	247.02	254.95	242.74	375.95	585.44	485.25
Trading Asset Securities	-	-	-	-	106.67	-
Cash & Short-Term Investments	247.02	254.95	242.74	375.95	692.11	485.25
Cash Growth	-10.73%	5.03%	-35.43%	-45.68%	42.63%	16.65%
Accounts Receivable	286.15	245.79	241.99	238.48	284.29	206.6
Other Receivables	6.97	8.06	19.25	12.32	19	83.52
Receivables	293.12	253.85	261.24	250.8	303.29	290.12
Inventory	250.02	288.71	278.58	335.39	285.09	216.36
Prepaid Expenses	-	-	-	-	0.76	1.52
Other Current Assets	88.53	12.71	3.31	33.64	33.63	14.91
Total Current Assets	878.69	810.22	785.87	995.78	1,315	1,008
Property, Plant & Equipment	1,440	1,454	1,433	1,532	1,286	1,224
Long-Term Investments	233.73	246.92	286.16	323.53	268.14	233.6
Other Intangible Assets	114.93	117.5	121.28	125.07	129.27	133.6
Long-Term Deferred Tax Assets	11.73	10.31	5.58	4.16	3.32	2.17
Long-Term Deferred Charges	29.05	22.38	20.42	18.68	12.14	5.48
Other Long-Term Assets	26.25	12.21	6.91	6.65	14.89	8.35
Total Assets	2,735	2,674	2,659	3,006	3,029	2,616
Accounts Payable	190.42	213.11	237.56	314.16	634.38	662.9
Accrued Expenses	27.35	39.12	32.84	38.54	42.22	28.1
Short-Term Debt	155.04	260.19	209.81	244.17	369.18	235.34
Current Portion of Long-Term Debt	12.04	9.51	42	85.9	0.5	-
Current Portion of Leases	-	1.15	3.38	5.07	4.43	-
Current Income Taxes Payable	16.29	5.64	2.66	4.83	10.87	1.83
Current Unearned Revenue	23.64	33.45	20.3	42	29.35	20.3
Other Current Liabilities	56.54	13.94	27.92	24.79	28.92	7.93
Total Current Liabilities	481.32	576.1	576.47	759.46	1,120	956.41
Long-Term Debt	10.79	10.79	48.69	178.39	30.32	10.79
Long-Term Leases	1.57	1.17	0.25	3.07	7.45	-
Long-Term Unearned Revenue	38.11	43.66	49.14	60.07	58.11	49.17
Long-Term Deferred Tax Liabilities	0.62	0.71	0.85	0.8	0.04	-
Total Liabilities	532.41	632.44	675.41	1,002	1,216	1,016
Common Stock	380.12	369.77	370.77	371.81	371.91	369.26
Additional Paid-In Capital	859.19	812.45	818.51	830.64	821.56	800.86
Retained Earnings	923.86	812.67	743.89	719.52	608.66	429.24
Treasury Stock	-40.57	-	-7.06	-14.4	-18.7	-
Comprehensive Income & Other	79.56	46.64	57.38	96.77	29.8	0.01
Total Common Equity	2,202	2,042	1,983	2,004	1,813	1,599
Shareholders' Equity	2,202	2,042	1,983	2,004	1,813	1,599
Total Liabilities & Equity	2,735	2,674	2,659	3,006	3,029	2,616
Total Debt	179.44	282.81	304.13	516.6	411.88	246.13
Net Cash (Debt)	67.58	-27.86	-61.39	-140.65	280.23	239.12
Net Cash Growth	-	-	-	-	17.19%	-
Net Cash Per Share	0.18	-0.08	-0.17	-0.38	0.75	0.67
Filing Date Shares Outstanding	380.12	369.77	370.77	371.81	371.91	369.26
Total Common Shares Outstanding	380.12	369.77	370.77	371.81	371.91	369.26
Working Capital	397.36	234.12	209.39	236.32	195.05	51.75
Book Value Per Share	5.79	5.52	5.35	5.39	4.88	4.33
Tangible Book Value	2,087	1,924	1,862	1,879	1,684	1,466
Tangible Book Value Per Share	5.49	5.20	5.02	5.05	4.53	3.97
Buildings	-	771.66	770.06	-	-	648.03
Machinery	-	1,476	1,559	-	-	1,048
Construction In Progress	-	115.74	2.57	40.48	52.85	137.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.